Schulze J, Toepfer M, Schroff K C, Aschhoff S, Remien J, Müller-Felber W, Endres S
Lancet. 1999 Nov 20;354(9192):1792-3. doi: 10.1016/S0140-6736(99)02881-0.
Upon clindamycin treatment a patient with Parkinson's disease showed marked tremor improvement which may be explained by clindamycin's ability to inhibit in-vitro nicotinergic, but not muscarinic signal transmission.